Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4007 Pharmacy

Closed 10-21 16:00:00 EDT

1,009.08

-4.94

-0.49%

High1,013.97	Low1,003.05	Vol598.00M
Open1,013.97	D1 Closing1,014.01	Amplitude1.08%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O11.02B	T/O Rate--	Tradable Shares0.00
P/B4.334952	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4007","market":"US","secType":"PLATE","nameCN":"Pharmacy","latestPrice":1009.075,"timestamp":1792612799999,"preClose":1014.0102,"halted":0,"volume":597997248,"delay":0,"changeRate":-0.004867,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-4.935181,"latestTime":"10-21 16:00:00 EDT","open":1013.97156,"high":1013.97156,"low":1003.04596,"amount":11022874564.845785,"amplitude":0.010775,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1792627200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.334952,"peRate":36.890829,"turnoverRate":0.013708,"increases":83,"decrements":104,"flats":4,"marketCap":3851968385410.375,"floatMarketCap":3697656782526},"requestUrl":"/m/hq/s/BK4007/tweets","defaultTab":"tweets","newsList":[{"id":"2677460614","title":"GlaxoSmithKline (GSK) Receives a Sell from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2677460614","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677460614?lang=en_us&edition=fundamental","pubTime":"2026-10-22 01:25","pubTimestamp":1792603537,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Zain Ebrahim maintained a Sell rating on GlaxoSmithKline today and set a price target of £17.00. According to TipRanks, Ebrahim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-sell-from-j-p-morgan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-sell-from-j-p-morgan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU2089284900.SGD","LU2111349929.HKD","LU0210528500.USD","IE00B3S45H60.SGD","LU0320765646.SGD","LU0314104364.USD","LU0912757837.SGD","BK4504","LU1244550577.SGD","LU1988902786.USD","KBWB","LU0795875169.SGD","LU1732799900.SGD","LU0528227936.USD","LU1244550494.USD","BK4127","GSK.UK","IE00BKVL7J92.USD","LU1989772840.SGD","LU0971096721.USD","LU2271345857.HKD","LU2487616109.SGD","LU0225283273.USD","LU0006306889.USD","LU0053666078.USD","LU1363072403.SGD","LU1720051017.SGD","IAI","LU1064131342.USD","LU1162221912.USD","LU1720051108.HKD","LU2028103732.USD","LU0106831901.USD","LU0158827948.USD","LU1244550221.USD","GSKH","BK4588","LU1791710400.SGD","LU2264538146.SGD","LU1548497426.USD","BK4007","GSK","LU1732800096.USD","LU1791710582.SGD","LU2357305700.SGD","BK4532","LU1074936037.SGD","LU0795875086.SGD","LU0106261372.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677051986","title":"Why This Pharma Pro Likes Johnson & Johnson, Eli Lilly, and Merck Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2677051986","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677051986?lang=en_us&edition=fundamental","pubTime":"2026-10-22 00:51","pubTimestamp":1792601460,"startTime":"0","endTime":"0","summary":"A wave of dealmaking and clinical breakthroughs has delivered a much-needed jolt to the healthcare sector after years of mixed performance.The iShares U.S. Pharmaceuticals exchange-traded fund and iShares Biotechnology ETF this year have gained 22% and 25%, respectively, beating a 13% gain in the S&P 500. In biotech, company-specific catalysts are driving a number of stocks to record highs. Moderna has surged nearly 716% on the back of positive cancer-vaccine trial data, while Revolution Medicines has more than doubled amid excitement over its \"miracle\" pancreatic cancer pill.Will the good times continue?We're firmly in a Fed rate-hiking cycle, and rising yields are a big part of the macro story. Typically, that isn't good for biotech, particularly small-cap valuations based on discounted cash flows. A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014914.USD","LU0234570918.USD","LU1674673428.USD","LLYX","LU0353189763.USD","LU2125909247.SGD","LU2505996681.GBP","LU2089984988.USD","SG9999014542.SGD","BK4139","LU0098860793.USD","LU0106261372.USD","LU0122379950.USD","BMED","LU0316494557.USD","BK4532","SG9999014880.SGD","LU0203347892.USD","LU2108987350.USD","BK4504","LU1037948897.HKD","LU1061106388.HKD","IE0004445015.USD","LU0109391861.USD","LU2462157665.USD","IE000WAW04H5.SGD","LU1153585028.USD","LU2129689514.USD","LU2750360997.AUD","LU0238689110.USD","JNJ","LU0985320562.USD","IE00BVYPNV92.GBP","LU1221951129.SGD","LU1267930813.SGD","LU1236620834.HKD","LU0965508806.USD","LU2129689431.USD","BK4501","LU0130517989.USD","BK4534","IE0002141913.USD","LU1674673691.USD","LU0345770308.USD","LU0689626769.HKD","LU0225283273.USD","LU0738911758.USD","LU2089284900.SGD","LU1551013425.SGD","IE00BWXC8680.SGD","IE00B4R5TH58.HKD","LU2264538146.SGD","SG9999015978.USD","IE000BZT7R73.USD","LU1929549753.HKD","LU0353189680.USD","LU1221951046.USD","LU0820561818.USD","LU2271345857.HKD","LU2456880835.USD","IE0004445239.USD","LU2111349929.HKD","LU2552382215.SGD","LU2433249047.HKD","LU1023059063.AUD","LU0256863811.USD","LU1066053197.SGD","LU1035775433.USD","SG9999017495.SGD","AGNG","LU1074936037.SGD","LU1244550494.USD","LU2361045086.USD","ELIL","LU2357627491.SGD","LU2756315664.SGD","LU1267930730.SGD","IE00BLSP4239.USD","IE000SO60NU8.SGD","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","LU0994945656.USD","IYH","LU0964807845.USD","SG9999018857.SGD","IE000F7OJYX1.SGD","SG9999014567.USD","LU1506573853.SGD","IE000M9KFDE8.USD","LU1868836757.USD","LU2237443382.USD","LU2430703251.USD","LU2430703095.HKD","LU0965509283.SGD","FTXH","LU1934455194.USD","LU1291159041.SGD","LU0385154629.USD","IHE","LU2236285917.USD","LU0079474960.USD","LU2168564222.USD","LU1121112475.USD","LU1732800096.USD","LU0477156953.USD","LU0345769128.USD","LU0109394709.USD","LU0114720955.EUR","LU0426412945.USD","SG9999013999.USD","SG9999015945.SGD","LU2896262040.SGD","LU1323610961.USD","LU0289739343.SGD","LU2491050154.USD","LU0198837287.USD","LU2211817866.USD","LU1941712264.USD","LU2361044865.SGD","LU0133085943.USD","LU2125909593.SGD","LU1069347547.HKD","BK4585","MHIP","LU2361044949.HKD","LU0345769631.USD","LU2211815571.USD","LU1145028129.USD","LU0545039389.USD","LU1232071149.USD","IE00B19Z3B42.SGD","RXL","LU1934455863.HKD","SGXZ81514606.USD","LU0820561909.HKD","LU1720051017.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0553294199.USD","LU1228905540.USD","GB00BDT5M118.USD","IE00BKDWB100.SGD","SGXZ31699556.SGD","LU2125154935.USD","IE000MB6IJN5.SGD","LU1989771016.USD","LU2746668461.USD","LU0471298694.HKD","LU0823434740.USD","LU0053666078.USD","LU1712237335.SGD","LU2213496289.HKD","LU2023250330.USD","LU0345770993.USD","IE0001KFT4U8.USD","LU0058720904.USD","LU0795875086.SGD","LU2430703178.SGD","LU0070302665.USD","IE00BFTCPJ56.SGD","LU0203202063.USD","LU2023251221.USD","BK4588","LU1868837136.USD","LU2168564495.EUR","SG9999014906.USD","BK4581","LU1988902786.USD","LU1718418525.SGD","LU1116320901.HKD","FHLC","SG9999018865.SGD","LU1280957306.USD","LLII","LU0266013472.USD","PAWZ","IE00BN29S564.USD","LU2237443549.SGD","LU2237443978.SGD","LU1989772840.SGD","LU0942090050.USD","LU0466842654.USD","LU0070217475.USD","LU1066051811.HKD","BK4551","LU2087625088.SGD","HRTS","LU1814569148.SGD","LU0472753341.HKD","LU1244550577.SGD","LU2265009873.SGD","BK4548","LU0683600562.USD","LU2133065610.SGD","IE00BVYPNW00.USD","LU2471134879.HKD","LU1720051108.HKD","JDOC","LU0069063385.USD","LU0648001328.SGD","IE0002270589.USD","SG9999001176.SGD","LU1585245621.USD","BK4568","BK4599","SG9999002232.USD","LU1035773651.USD","LU0203345920.USD","SG9999015952.SGD","LU0943347566.SGD","LU0210528500.USD","MRK","SG9999001176.USD","LU0640476718.USD","IE00BKPKM429.USD","CANC","LU2112291526.USD","LU1691799644.USD","LU2168564065.EUR","LU2324357040.USD","LU0208291251.USD","LU2491049909.HKD","LU2468319806.SGD","LU0072461881.USD","LU0094547139.USD","LU2023250843.SGD","LU0889566641.SGD","LU0912757837.SGD","LU2106854487.HKD","LU1551013342.USD","BK4007","LU0426417589.USD","LU0661504455.SGD","LU0859254822.USD","LU1066051225.USD","IE00BFSS8Q28.SGD","LU2505996509.AUD","CURE","LU0210536198.USD","LU0889565916.HKD","LLYZ","LU1064131342.USD","LU2462591350.SGD","SGXZ99366536.SGD","LU1923622614.USD","BK4592","LU2487616109.SGD","LU0203201768.USD","LU2168563687.JPY","TRUH","LU1917777945.USD","LU1934455277.USD","TMED","LU0320765992.SGD","LU2089283258.USD","LU1037948541.HKD","XLV","LU0265550359.USD","LU1571399168.USD","LU0980610538.SGD","LU1069344957.HKD","IE00B3PB1722.GBP","LU1043141396.HKD","LU0545562505.USD","LU0057025933.USD","IE00BFSS7M15.SGD","LU1116320737.USD","LU0061475181.USD","IE00B1XK9C88.USD","LU1261432733.SGD","SG9999014575.USD","LU0354030511.USD","LU2028103732.USD","BK4550","IDNA","LU2357305700.SGD","IE00B3T34201.USD","LU0256863902.USD","IE00BFXG1179.USD","LU2592432038.USD","LU0965509010.AUD","MRNA","LU0323591593.USD","LU0289961442.SGD","IXJ","IE00B19Z3581.USD","IE00BLSP4452.SGD","LU1894683264.USD","LU2552382058.USD","LU0861579265.USD","LU1989772923.USD","MEDI","LU2125154778.USD","IE00B7KXQ091.USD","LU0234572021.USD","IE00BDGV0183.EUR","IE0005OL40V9.USD","BK4533","LU0130102774.USD","LU0211331839.USD","LU0823434583.USD","LU1804176565.USD","LU2471134523.USD","LU0965509101.SGD","IE00B42XCP33.USD","LU2746668974.SGD","LU1057294990.SGD","LU1496350502.SGD","LU2237443622.USD","OZEM","IE00BGHQF631.EUR","LU0158827948.USD","LU2347655156.SGD","SG9999014898.SGD","LU1003077747.HKD","LU0417517546.SGD","IE00B1BXHZ80.USD","LU1974910355.USD","LU2403377893.USD","LU0320765646.SGD","LU1059921491.USD","LU0174119429.USD","LU1228905037.USD","LU2237438978.USD","LU2417539215.USD","IE00BJJMRY28.SGD","LU0320765059.SGD","LU0511384066.AUD","THNR","ILDR","PJP","SG9999015986.USD","LU0820562030.AUD","LU1366192091.USD","LU1430594728.SGD","LU1979441026.SGD","LU0787776722.HKD","LU2129689605.HKD","LU1935042991.SGD","LU0158827781.USD","LU0672654240.SGD","LU1868836591.USD","LU2756315318.SGD","LU2237443465.HKD","LU0708995401.HKD","LU2491050071.SGD","LU0432979614.USD","BK4516","IE00B775H168.HKD","LU0786609619.USD","IE0009355771.USD","LU0289739699.SGD","LU1914381329.SGD","LU0823416689.USD","LU0868494708.USD","LU1093756168.USD","LU1032955483.USD","LU1236620750.USD","LU0124676726.USD","LU0354030438.USD","LU0006306889.USD","MEDX","LU1941712348.USD","LU2360106947.USD","GDOC","IE00BK4W5M84.HKD","LU2237443895.HKD","GNOM","LLY","SGXZ51526630.SGD","LU0795875169.SGD","SG9999002224.SGD","LU1032466523.USD","SGXZ80539844.SGD","LU2602419157.SGD","LU0162691827.USD","IE0034235303.USD","LU2023250504.SGD","LU1201861249.SGD","LU2471134952.CNY","SG9999015358.SGD","LU1196500208.SGD","LU1162221912.USD","LU2461242641.AUD","LU0792757196.USD","LU0882574139.USD","MRNX","LU0689472784.USD","LU1548497426.USD","LU1894683348.USD","LU1066051498.USD","LU1778281490.HKD","MRNY","SG9999001440.SGD","LU1244550221.USD","LU0456855351.SGD","LU1732799900.SGD","VHT","WDNA","LU1629891620.HKD","IE0000B7K699.USD","LU2063271972.USD","BK4559","IE00BJJMRX11.SGD","LU1868837300.USD","LU0882574055.USD","LU0868494617.USD","PPH","LU1127390331.HKD","IE00BJLML261.HKD","LU1868836914.USD","IE00B2B36J28.USD","IE00BK4W5L77.USD","IE00BBT3K403.USD","ELIS","LU2750360641.GBP","LU1983299246.USD","IE00BN8TJ469.HKD","LU2471134796.USD","LU0320765489.SGD","LU2168564149.EUR","LU2552382132.HKD","LU1093756325.SGD","LU0097036916.USD","LU0096364046.USD","LU1623119135.USD","SGXZ57979304.SGD","IE00B7SZLL34.SGD","LU2360032135.SGD","LU1699723380.USD","LU1043141123.HKD","SG9999015341.SGD","LU0011850046.USD","LU0265550946.USD","SG9999014559.SGD","LU0471298777.SGD","IE00B4JS1V06.HKD","IE00BJT1NW94.SGD","LU0949170772.SGD","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677060564","title":"Analysts Conflicted on These Healthcare Names: Roivant Sciences (ROIV), Alnylam Pharma (ALNY) and Haemonetics (HAE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2677060564","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677060564?lang=en_us&edition=fundamental","pubTime":"2026-10-22 00:40","pubTimestamp":1792600810,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roivant Sciences (ROIV), Alnylam Pharma (ALNY) and...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-roivant-sciences-roiv-alnylam-pharma-alny-and-haemonetics-hae-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-roivant-sciences-roiv-alnylam-pharma-alny-and-haemonetics-hae-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HAE","LU1169590202.USD","BK4581","BK4137","BK4198","LU0320765992.SGD","BK4139","ROIV","PBE","HCSG","BK4548","LU0882574055.USD","LU0029874061.USD","LU0114720955.EUR","LU0109394709.USD","IE0034390439.USD","XBI","GNMX","LABU","ALNY","LU0889565916.HKD","LU0205193047.USD","IE00BLDYK493.USD","PTH","IE00B19Z6F94.USD","BK4588","LU1169589451.USD","LU0205194284.USD","BK4007","XLV","LU0012050646.USD","IE00B64QTZ34.USD","LU0128526141.USD","BK4585","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677605545","title":"Roivant Rises as Drug Succeeds in Two Late-Stage Trials for Eye Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2677605545","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677605545?lang=en_us&edition=fundamental","pubTime":"2026-10-22 00:33","pubTimestamp":1792600429,"startTime":"0","endTime":"0","summary":"BUZZ-Roivant rises as drug succeeds in two late-stage trials for eye disease** Shares of RoivantROIV.Orise 4.35% to $36.44** Co's drug brepocitinibmeets main goalsof two late-stage trials** The pill, which is branded as Lisraya, was more effective than placebo in treating the inflammatory eye disease non-infectious uveitis ** Adds intends to file an application for brepocitinib for the treatment of NIU in the first half of 2027** \"We believe this is a major win for brepocitinib given that NIU represents a lucrative market opportunity with especially high unmet needs,\" Piper Sandler says** Lisraya isapprovedfor dermatomyositis, a condition that causes painful skin rashes and progressive muscle weakness** Including sessions moves, ROIV up 68% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nL4N4671JL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4007","BK4139","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677605629","title":"Palisade Bio Advances ASCENTRA-UC Trial, PALI-2108 Moves Deeper Into Ulcerative Colitis Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2677605629","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677605629?lang=en_us&edition=fundamental","pubTime":"2026-10-22 00:30","pubTimestamp":1792600246,"startTime":"0","endTime":"0","summary":"Palisade Bio, Inc. ($PALI) announced an update on their ongoing clinical study. The ASCENTRA-UC study is a phase 2 trial run by Palisade Bio, Inc. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/palisade-bio-advances-ascentra-uc-trial-pali-2108-moves-deeper-into-ulcerative-colitis-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/palisade-bio-advances-ascentra-uc-trial-pali-2108-moves-deeper-into-ulcerative-colitis-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677056446","title":"Bayer Expands Real-World Kidney Data For Finerenone, Eyeing Long-Term Upside For BAYRY","url":"https://stock-news.laohu8.com/highlight/detail?id=2677056446","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677056446?lang=en_us&edition=fundamental","pubTime":"2026-10-22 00:30","pubTimestamp":1792600219,"startTime":"0","endTime":"0","summary":"Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Bayer AG (BAYRY) is preparing a new real world study in Mexico to track fine...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bayer-expands-real-world-kidney-data-for-finerenone-eyeing-long-term-upside-for-bayry?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bayer-expands-real-world-kidney-data-for-finerenone-eyeing-long-term-upside-for-bayry?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677860309","title":"Novartis AG Rises Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2677860309","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677860309?lang=en_us&edition=fundamental","pubTime":"2026-10-22 00:15","pubTimestamp":1792599300,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  advanced 0.3% to CHF126.88 Wednesday on what proved to be an overall positive trading session for the stock market, with the Swiss Market Index SMI Index  rising 0.5% to 14,552.39.Novartis AG closed CHF5.80 below its 52-week high of CHF132.68, which the company reached on September 3, 2026.Trading volume was 2,940,668, compared to the 50-day average trading volume of 3,068,489.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","BK4578","NVS","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","MEDX","BK4532","BK4007","LU0070302665.USD","LU0211331839.USD","BK4585","LU0208291251.USD","LU0320765489.SGD","PPH","BK4588","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677711603","title":"Hikma Pharmaceuticals Climbs Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2677711603","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677711603?lang=en_us&edition=fundamental","pubTime":"2026-10-22 00:08","pubTimestamp":1792598880,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Hikma Pharmaceuticals PLC  advanced 1.21% to GBP16.72 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index  rising 0.19% to 10,752.88.Hikma Pharmaceuticals PLC closed 10.35% short of its 52-week high of GBP18.65, which the company reached on October 31st.Trading volume totaled 198,587, compared to the 50-day average of 655,532.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HKMPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677605338","title":"Aurora UK Alpha adjusts capital structure with latest share buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2677605338","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677605338?lang=en_us&edition=fundamental","pubTime":"2026-10-22 00:07","pubTimestamp":1792598849,"startTime":"0","endTime":"0","summary":"Aurora Investment Trust PLC ( ($GB:ARR) ) just unveiled an announcement. Aurora UK Alpha PLC has purchased 20,000 of its own ordinary shares at 257...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aurora-uk-alpha-adjusts-capital-structure-with-latest-share-buyback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aurora-uk-alpha-adjusts-capital-structure-with-latest-share-buyback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BRKW","BRKU","BK4557","ACKY","BRKC","ACTV","ACB","BRKL","BRKD","MSOS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677603233","title":"Novo Nordisk A/S Series B Stock Rises Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2677603233","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677603233?lang=en_us&edition=fundamental","pubTime":"2026-10-22 00:03","pubTimestamp":1792598580,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B rose 0.2% to DKK261.70 Wednesday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 0.8% to 2,622.59.This was the stock's second consecutive day of gains.The company closed DKK148.25 below its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 3,706,533, compared to the 50-day average trading volume of 4,793,554.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1093756325.SGD","BK4532","PPH","NVO","BK4007","BK4585","IE00BKVL7J92.USD","NVOH","NVOC","OZEM","IE00BZ1G4Q59.USD","THNR","LU0154236417.USD","LU1093756168.USD","NVOX","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677260331","title":"Novartis Says European Commission Approved Cosentyx for Polymyalgia Rheumatica Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2677260331","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677260331?lang=en_us&edition=fundamental","pubTime":"2026-10-21 23:36","pubTimestamp":1792597010,"startTime":"0","endTime":"0","summary":"Novartis  said Wednesday that the European Commission has approved Cosentyx for the treatment of adults with polymyalgia rheumatica, a common inflammatory rheumatic disease, characterized by acute pain and stiffness in the shoulders, neck, and hips.The recommended dose for Cosentyx is 150 mg by subcutaneous injection with initial dosing at weeks zero to four, followed by monthly maintenance dosing in combination with a tapering course of glucocorticoids, Novartis said.Additional regulatory reviews of Cosentyx in polymyalgia rheumatica are ongoing in US and Japan, Novartis further said.Price: 153.54, Change: -0.10, Percent Change: -0.06","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","BK4578","NVS","IE00BJJMRZ35.SGD","EPV","IE00BJT1NW94.SGD","IE0002141913.USD","MEDX","BK4532","BK4007","LU0070302665.USD","LU0211331839.USD","BK4585","LU0208291251.USD","LU0320765489.SGD","PPH","BK4588","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677608757","title":"Novartis announces European Commission approval for Cosentyx in PMR","url":"https://stock-news.laohu8.com/highlight/detail?id=2677608757","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677608757?lang=en_us&edition=fundamental","pubTime":"2026-10-21 23:10","pubTimestamp":1792595415,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that the European Commission has approved Cosentyx for the treatment of adults with polymyalgia rheumatica, or PMR, who ha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-european-commission-approval-for-cosentyx-in-pmr-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-european-commission-approval-for-cosentyx-in-pmr-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","IE0009355771.USD","BK4007","BK4588","IE0002141913.USD","LU0320765489.SGD","BK4578","IE00B2B36J28.USD","NVS","BK4585","PPH","IE00BJT1NW94.SGD","BK4532","LU0070302665.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","EPV","LU0211331839.USD","PMR","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677608970","title":"Moderna is About to Release the Trial Results for Its Cancer Vaccine. a Lot is Riding on This Data.","url":"https://stock-news.laohu8.com/highlight/detail?id=2677608970","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677608970?lang=en_us&edition=fundamental","pubTime":"2026-10-21 23:00","pubTimestamp":1792594800,"startTime":"0","endTime":"0","summary":"\"The vaccine, called intismeran, is a radical new approach to treating melanoma that uses genetic data from the patient's tumor to create a customized vaccine. Patients undergo surgery to have their tumor removed. Scientists sequence the tumor to identify mutated proteins, which are also called neoantigens, and then create an mRNA strand using up to 34 of the neoantigens that they believe will produce the best immune response. The whole process takes about six weeks.\"It is truly a one-therapy-per-patient approach,\" Mehnert said. \"That vaccine, once it's made - it can only be used for you.\"'We believe the outcomes will support the excitement, and we see low probability of data that resolve the main debates.'Daina Graybosch,","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","LU1989771016.USD","BMED","LU1023059063.AUD","LU0058720904.USD","LU1061106388.HKD","IXJ","LU2125154935.USD","LU2357627491.SGD","LU0234572021.USD","LU1162221912.USD","IE00BSNM7G36.USD","BK4568","LU0211331839.USD","IE0009355771.USD","LU0942090050.USD","SG9999015341.SGD","LU1699723380.USD","LGHT","LU0472753341.HKD","LU0130102774.USD","SG9999001176.USD","LU1571399168.USD","LU0124676726.USD","IE00BJT1NW94.SGD","SG9999014542.SGD","LU1066051225.USD","JDOC","LU2089984988.USD","LU0648001328.SGD","IE00BN8TJ469.HKD","LU2112291526.USD","LU0965509010.AUD","IE00BBT3K403.USD","IDNA","LU2417539215.USD","LU1116320737.USD","RXL","BK4532","LU0162691827.USD","LU1236620750.USD","LU1291159041.SGD","BK4139","BK4501","LU2468319806.SGD","SG9999013999.USD","LU1941712264.USD","LU1974910355.USD","LU1934455277.USD","LU0868494617.USD","PAWZ","LU1066053197.SGD","LU1057294990.SGD","SG9999014567.USD","HRTS","LU1201861249.SGD","LU0069063385.USD","GDOC","LU1037948541.HKD","LU2125909593.SGD","LU1923622614.USD","SG9999014575.USD","LU0289739343.SGD","LU0057025933.USD","LU0965509283.SGD","BK4534","IE00BJJMRZ35.SGD","LU1917777945.USD","LU0432979614.USD","BK4588","IYH","LU0320765489.SGD","SG9999001440.SGD","SG9999001176.SGD","IE00BLSP4239.USD","LU0289739699.SGD","LU0130517989.USD","SG9999014559.SGD","BK4551","VHT","SG9999002232.USD","LU1989772840.SGD","BK4516","SGXZ57979304.SGD","LU0203347892.USD","LU0238689110.USD","LU1934455194.USD","LU2491050154.USD","WDNA","BK4585","BK4533","LU0070302665.USD","MRK","LU2433249047.HKD","LU2491050071.SGD","LU0985320562.USD","BK4548","LU0861579265.USD","MRNY","LU0265550359.USD","LU0965508806.USD","LU1066051811.HKD","LU0980610538.SGD","LU1934455863.HKD","LU0072461881.USD","LU1035773651.USD","LU1037948897.HKD","LU0477156953.USD","IE00B4R5TH58.HKD","LU0965509101.SGD","LU2023250504.SGD","IHE","LU2361044949.HKD","IE000M9KFDE8.USD","TRUH","IE00BLSP4452.SGD","GNOM","LU0265550946.USD","LU1093756168.USD","MRNA","LU0289961442.SGD","LU1093756325.SGD","LU1941712348.USD","LU0266013472.USD","LU1983299246.USD","LU2360032135.SGD","LU0868494708.USD","LU0122379950.USD","LU0208291251.USD","BK4559","IE00B1BXHZ80.USD","LU1066051498.USD","LU0203345920.USD","LU2491049909.HKD","LU0689626769.HKD","LU0106261372.USD","LU2361045086.USD","LU1116320901.HKD","LU0823416689.USD","LU2106854487.HKD","LU2236285917.USD","LU0511384066.AUD","BK4007","IE0002141913.USD","FTXH","LU0098860793.USD","LU2125154778.USD","LU2456880835.USD","LU1069347547.HKD","IE00BFTCPJ56.SGD","XLV","LU1236620834.HKD","LU2023250843.SGD","LU1585245621.USD","BK4550","LU2461242641.AUD","MRNX","SG9999015358.SGD","PPH","LU0320765646.SGD","LU0859254822.USD","LU2324357040.USD","LU1929549753.HKD","LU1032466523.USD","LU2361044865.SGD","SG9999002224.SGD","LU0006306889.USD","LU2125909247.SGD","FHLC","LU1989772923.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677160891","title":"Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Maze Therapeutics, Inc. (MAZE) and Abbott Laboratories (ABT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2677160891","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677160891?lang=en_us&edition=fundamental","pubTime":"2026-10-21 22:50","pubTimestamp":1792594210,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ionis Pharmaceuticals (IONS), Maze Therapeutics, Inc. (MAZE) and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ionis-pharmaceuticals-ions-maze-therapeutics-inc-maze-and-abbott-laboratories-abt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ionis-pharmaceuticals-ions-maze-therapeutics-inc-maze-and-abbott-laboratories-abt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1691799644.USD","BK4504","IE00B4R5TH58.HKD","MAZE","BK4139","LU0432979614.USD","LU0170899867.USD","BK4585","LU0114720955.EUR","BK4007","LU1023059063.AUD","LU2237957902.USD","LABU","IE00BJJMRZ35.SGD","BK4592","LU2211815571.USD","LU0128526141.USD","ABT","IE0009355771.USD","LU0320765489.SGD","LU1721429741.USD","BK4533","LU0070302665.USD","LU2133065610.SGD","LU0208291251.USD","LU0266013472.USD","IHI","LU0234572021.USD","LU1670628061.USD","LU1721429402.USD","IE00BFTCPJ56.SGD","LU2324357040.USD","LU1914381329.SGD","HCSG","LU2237957811.SGD","LU0211331839.USD","LU0868494617.USD","LU0289739699.SGD","IONS","TMED","SG9999002232.USD","XLV","LU0058720904.USD","LU1983299246.USD","IE0002141913.USD","LU1989763690.USD","XBI","PJP","IE00BJT1NW94.SGD","LU1670627923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677677697","title":"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Eli Lilly & Co (LLY) and Sanofi (OtherSNYNF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2677677697","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677677697?lang=en_us&edition=fundamental","pubTime":"2026-10-21 21:50","pubTimestamp":1792590606,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pfizer (PFE), Eli Lilly & Co (LLY) and Sanofi (SNY...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-eli-lilly-co-lly-and-sanofi-othersnynf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-eli-lilly-co-lly-and-sanofi-othersnynf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0158827781.USD","LLYX","LU2237443465.HKD","LU0306807586.USD","LU0345770308.USD","LU1868836914.USD","LU1894683264.USD","IE00B775H168.HKD","LU0471298694.HKD","LU2168564149.EUR","LU0306806265.USD","LU0323591593.USD","LU1983299246.USD","LU2108987350.USD","LU2213496289.HKD","LU1720051017.SGD","LU2023250330.USD","SG9999014914.USD","THNR","LU1232071149.USD","LU2357305700.SGD","LU1035775433.USD","LU1814569148.SGD","LU2168564495.EUR","BK4585","LU2089984988.USD","IE00BJJMRY28.SGD","LU2596442595.SGD","LU0689472784.USD","BK4516","LU2471134879.HKD","LU1979441026.SGD","LU2023250504.SGD","LU0417517546.SGD","LU2468319806.SGD","IE0004445239.USD","LU1066053197.SGD","LU1236620834.HKD","LU1551013425.SGD","LU2360106947.USD","SG9999001176.USD","IE00BKPKM429.USD","LU1720051108.HKD","LU2211815571.USD","LU0266013472.USD","SG9999014898.SGD","LU0985481810.HKD","SG9999018865.SGD","SGXZ51526630.SGD","LLII","SG9999011175.SGD","LU2746668974.SGD","LU1894683348.USD","LU0122379950.USD","LU0353189680.USD","IE00BWXC8680.SGD","LU2471134523.USD","LU2746668461.USD","LU1989771016.USD","IE00BN29S564.USD","LU2089283258.USD","LU0354030511.USD","IE00B1XK9C88.USD","LU0061475181.USD","LU0096364046.USD","LU1691799644.USD","LU2264538146.SGD","ELIL","LU2491049909.HKD","SG9999014880.SGD","IE00B19Z3B42.SGD","LU2491050071.SGD","ILDR","LU1093756325.SGD","LU2237443622.USD","LU2271345857.HKD","LU2462157665.USD","LU1127390331.HKD","LU2756315664.SGD","AGNG","IE00B3T34201.USD","LU1804176565.USD","LU0786609619.USD","IE00BFSS7M15.SGD","LU1061106388.HKD","LU0820561909.HKD","LU0225284248.USD","LU1868837300.USD","IE00BFTCPJ56.SGD","LU1623119135.USD","LU0882574055.USD","LU2756315318.SGD","SG9999015952.SGD","LU1712237335.SGD","LU2236285917.USD","IE00BBT3K403.USD","LU2237443549.SGD","IE00BK4W5M84.HKD","IE0002270589.USD","LU2237438978.USD","IE00B1BXHZ80.USD","LU2491050154.USD","LU1988902786.USD","WDNA","LU2111349929.HKD","JDOC","LU0708995401.HKD","LU1551013342.USD","LU1548497426.USD","LU1629891620.HKD","LU2750360641.GBP","SGXZ99366536.SGD","CURE","LLY","LU0011850046.USD","LU2265009873.SGD","LU2361044865.SGD","LU2552382058.USD","LU0882574139.USD","LU1291159041.SGD","LU1974910355.USD","LU0234572021.USD","SG9999002224.SGD","LU0225771236.USD","LU2461242641.AUD","LU2237443895.HKD","LU1153585028.USD","LU0320765992.SGD","BK4550","LU0321505868.SGD","LU1093756168.USD","LU1323610961.USD","LU1868836757.USD","IE00B4R5TH58.HKD","BK4534","BK4007","LU0466842654.USD","BK4568","MHIP","LU1868836591.USD","PPH","BK4599","LU0109394709.USD","LU0353189763.USD","LU0256863902.USD","LU0097036916.USD","SG9999018857.SGD","LU0432979614.USD","LU0203202063.USD","LU0225283273.USD","LU0058720904.USD","BK4533","LU2471134796.USD","LU0114720955.EUR","LU0683600562.USD","LU0868494617.USD","IHE","LU0385154629.USD","PJP","IE00BJJMRX11.SGD","LU2602419157.SGD","LU0345770993.USD","LLYZ","SG9999015945.SGD","IE0002141913.USD","LU0210536198.USD","SGXZ31699556.SGD","LU1868837136.USD","IE00BJT1NW94.SGD","LU0174119429.USD","LU2106854487.HKD","IE0005OL40V9.USD","LU0320765059.SGD","LU2168563687.JPY","LU2361044949.HKD","LU0109391861.USD","BK4588","IE000M9KFDE8.USD","LU1145028129.USD","IE00BJLML261.HKD","MEDX","LU0289739699.SGD","SG9999002232.USD","SGXZ57979304.SGD","LU2087625088.SGD","BK4592","LU0672654240.SGD","RXL","LU1069344957.HKD","IE0009355771.USD","LU0094547139.USD","LU0321505439.SGD","FHLC","LU2237443978.SGD","IXJ","LU2896262040.SGD","LU1280957306.USD","LU0238689110.USD","LU1057294990.SGD","FTXH","LU0964807845.USD","IE00BLSP4452.SGD","LU2089284900.SGD","LU1236620750.USD","LU2417539215.USD","IYH","VHT","MEDI","SG9999015978.USD","LU2211817866.USD","IE0001KFT4U8.USD","LU0316494557.USD","LU0787776722.HKD","LU0823434740.USD","LU0198837287.USD","TRUH","LU0820562030.AUD","IE00BK4W5L77.USD","GDOC","LU2063271972.USD","LU2552382215.SGD","LU0079474960.USD","LU2471134952.CNY","LU2023251221.USD","IE00BFSS8Q28.SGD","LU0456855351.SGD","LU1917777945.USD","LU2168564222.USD","LU2456880835.USD","LU2750360997.AUD","LU1883839398.USD","OZEM","IE00B2B36J28.USD","LU0889565916.HKD","SG9999017495.SGD","LU2125154778.USD","LU2462591350.SGD","LU2324357040.USD","IE00BKDWB100.SGD","LU1023059063.AUD","IE00B7KXQ091.USD","LU2112291526.USD","LU0256863811.USD","LU2360032135.SGD","SG9999003800.SGD","LU0943347566.SGD","SGXZ81514606.USD","LU0203201768.USD","SG9999001176.SGD","LU0823416689.USD","GB00BDT5M118.USD","LU1267930730.SGD","LU2361045086.USD","LU0823434583.USD","SG9999015986.USD","LU2552382132.HKD","LU0170899867.USD","ELIS","LU2237443382.USD","LU0106261372.USD","LU1366192091.USD","LU2028103732.USD","IE00BLSP4239.USD","IE00B19Z3581.USD","PFE","SG9999013999.USD","IE00BJJMRZ35.SGD","LU0640476718.USD","LU2125154935.USD","SG9999014906.USD","BK4581","LU0133085943.USD","TMED","IE0004445015.USD","IE00B4JS1V06.HKD","LU0158827948.USD","LU1066051498.USD","LU0471298777.SGD","LU0820561818.USD","CANC","LU1064131342.USD","HRTS","LU0354030438.USD","LU0006306889.USD","LU2168564065.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677672425","title":"Lexaria Bioscience reaches full enrollment in GLP-1-H26-7 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2677672425","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677672425?lang=en_us&edition=fundamental","pubTime":"2026-10-21 21:35","pubTimestamp":1792589744,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience (LEXX) reports that full enrollment has been reached and dosing continues on schedule with Human Pilot Study #7 which is evaluat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexaria-bioscience-reaches-full-enrollment-in-glp-1-h26-7-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexaria-bioscience-reaches-full-enrollment-in-glp-1-h26-7-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LEXX","BK4007","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677672967","title":"NVIDIA, Microsoft, Merck KGaA Collaborate on AI Patient Support Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2677672967","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677672967?lang=en_us&edition=fundamental","pubTime":"2026-10-21 21:33","pubTimestamp":1792589616,"startTime":"0","endTime":"0","summary":"NVIDIA , Microsoft , Dawn Health, and German science and tech firm Merck KGaA are collaborating to create a model for patient support programs, the latter said Wednesday.Merck KGaA said the companies intend to combine artificial intelligence services and digital health product design, pharmaceutical and clinical expertise, and enterprise technology to make patient support more personalized and responsive.Merck KGaA said it is designing an integrated support ecosystem targeted to the needs of people living with rare tumors, their disease state, and circumstances.The company said it plans to pilot the model in key European markets once technical feasibility is confirmed and regulatory requirements are met, initially focusing on rare tumors, specifically desmoid tumors and neurofibromatosis type 1 with plexiform neurofibromas.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE000YTNTUN2.SGD","IE00B1BXHZ80.USD","IE00BJTD4N35.SGD","LU0466842654.USD","LU1989764664.SGD","LU0096364046.USD","LU2471134523.USD","NVC","LU1261432733.SGD","BK4592","LU0234570918.USD","BK4576","LU1244550494.USD","LU2413666699.HKD","LU2506952097.USD","NVII","LU1670756490.USD","LU1323610961.USD","LU2083900584.USD","LU0738911758.USD","NVD2.UK","LU0788109477.HKD","IE0004091025.USD","LU0072461881.USD","LU1803068623.USD","IE000M9KFDE8.USD","LU2462157665.USD","LU0289961442.SGD","FAI","LU2362541513.USD","LU0342679015.USD","LU1852331112.SGD","LU2211815571.USD","LU0274383776.USD","LU0757359954.USD","GB00B4LPDJ14.GBP","LU1228905037.USD","LU2347655156.SGD","LU0006306889.USD","LU1496350171.SGD","NVDQ","NVDS.UK","LU0683600562.USD","LU1221951129.SGD","LU1551013342.USD","IXN","LU1235294995.USD","LU0211331839.USD","IETC","LU0476273544.USD","LU1642822529.SGD","IE00BZ1G4Q59.USD","LU0719512351.SGD","LU0871640123.AUD","LU1242518931.SGD","3NVD.UK","SG9999014575.USD","LU2413666426.HKD","LU1861558580.USD","LU2023251221.USD","LU2023250504.SGD","LU1697837992.HKD","LU2746668461.USD","LU2168563687.JPY","LU2430703251.USD","LU2360107168.USD","LU2097829019.USD","LU2294711713.HKD","LU2125909916.SGD","LU1400636491.USD","LU1066051498.USD","LU1043141123.HKD","SMHX","IE00BFXG0V08.USD","LU2237443549.SGD","LU1629891620.HKD","LU0308772762.SGD","LU0820561818.USD","BK4550","LU2092627202.USD","NVIW.SI","LU2250418816.HKD","SG9999002224.SGD","NVDO","LU0879622024.SGD","LU1430594728.SGD","LU2552382058.USD","LU1951198990.SGD","LU0787776722.HKD","BK4554","SG9999014898.SGD","IE0000B7K699.USD","LU1267930813.SGD","LU1814569148.SGD","LU0456855351.SGD","LU0079474960.USD","LU0820562030.AUD","LU0127658192.USD","LU2237443465.HKD","LU2420271590.USD","LU1037948541.HKD","LU1821325948.USD","LU2148611432.USD","LU0889566641.SGD","BK4528","LU0965509283.SGD","LU1935042488.USD","LU2471134796.USD","LU0784385840.USD","NVD","XLK","LU2125909247.SGD","BK4581","LU0187121727.USD","LU0056508442.USD","SNPE","LU0494093205.USD","LU2487616109.SGD","LU0157215616.USD","LU1914381329.SGD","LU0061474960.USD","IE00B3S45H60.SGD","LU1084165304.USD","BK4141","IE000WAW04H5.SGD","LU1880398471.USD","LU1066051811.HKD","SGXZ81514606.USD","NULC","LU0251132253.USD","LU2357125470.USD","OGIG","07388","LU1074936037.SGD","TDIV","LU0861579265.USD","LU2237957902.USD","LU0726765562.USD","LU0894486033.HKD","LU1868836591.USD","LU2272731865.HKD","LU0316494557.USD","BK4549","LU2361044949.HKD","LU1979441026.SGD","LU2506951792.HKD","LU0124676726.USD","LU2506952170.USD","LU1923622614.USD","LU0957791311.USD","LU1989773731.SGD","LU0557290698.USD","LU1699723380.USD","HK0000914686.HKD","USD","LU1670711040.USD","LU0390134368.USD","LU2860962120.EUR","LU1917777945.USD","LU1506573853.SGD","IE00BN8TJ469.HKD","LU2756315664.SGD","IE00B19Z3581.USD","LU0070302665.USD","LU0323591593.USD","LU1815333072.USD","LU0170899867.USD","LU1791710582.SGD","HK0000532082.HKD","SG9999014906.USD","SG9999017495.SGD","LU0289941410.SGD","IE000F7OJYX1.SGD","MSFL","IE00B4YYXB79.USD","LU1670711123.USD","MKKGY","09788","LU1868837136.USD","SNVD.UK","IE00BYXW3230.USD","AGOX","BK4577","LU1983260115.SGD","IE00BYQQ9H92.USD","LU2756315318.SGD","IE00B775H168.HKD","LU0795875086.SGD","IE00BK4W5L77.USD","LU0211328371.USD","LU0823417653.USD","LU1032466523.USD","IE00BQXX3F31.USD","LU2023250843.SGD","ROM","BK4007","LU0823414478.USD","LU2954938101.SGD","LU0689626769.HKD","LU0097036916.USD","BK4551","LU0950375773.USD","LU1623119135.USD","LU2237443978.SGD","LU1144417596.USD","IE00BVYPNW00.USD","LU0708995401.HKD","LU0158827781.USD","LU0882574139.USD","LU1645745479.HKD","SG9999014567.USD","BK4605","LU2506951958.HKD","BK4538","LU1116320737.USD","LU0345774391.USD","LU1116320901.HKD","LU0154236417.USD","LU2108987350.USD","IE00BFSS7M15.SGD","IE00B4JS1V06.HKD","LU1181866309.USD","LU0784384876.USD","LU1366333091.USD","IE00B19Z3B42.SGD","LU1267930490.SGD","LU1791710400.SGD","BK4532","IE00B5949003.HKD","LU2322448957.HKD","LU2357305700.SGD","IE00BLSP4239.USD","HK0000819398.USD","LU0545039389.USD","LU2272731600.USD","LU1582986359.USD","SG9999018857.SGD","LU2417539215.USD","LU0061475181.USD","LU0238689110.USD","LU0314106906.USD","BK4529","LU1861559042.SGD","IE00BQXX3C00.GBP","BK4097","CMAG","LU0994945656.USD","LU1400636574.HKD","HK0000320223.HKD","NVDB","IE00BMPRXN33.USD","LU0057025933.USD","LU2028103732.USD","LU2092937221.SGD","LU2750360997.AUD","IE0002270589.USD","AIPI","LU2213496289.HKD","LU2750360641.GBP","LU1989772840.SGD","LU1037948897.HKD","LU0553294199.USD","LU0171293334.USD","LU1267930573.SGD","LU0138981039.USD","LU0889565833.HKD","LU2403377893.USD","LU2592432038.USD","LU1236620834.HKD","LU1935042215.USD","MSFD","LU0323240290.USD","LU2097344357.USD","SG9999000418.SGD","LU1232071149.USD","LU1934455277.USD","SOXQ","GB00B4QBRK32.GBP","LU0444973449.USD","LU1548497426.USD","LU1551013425.SGD","IGV","LU0077335932.USD","IE00BGHQF631.EUR","LU2271345857.HKD","LU1720051108.HKD","MSFU","BK4534","LU1992135399.USD","IE00BZ199S13.USD","IE00BD6J9T35.USD","LU0894485498.HKD","LU0354030511.USD","LU0426412945.USD","LU2264538146.SGD","LU2471134879.HKD","LU2236285917.USD","LU2265009873.SGD","MSFY","LU0289960550.SGD","LU2237443895.HKD","BK4516","LU2433249047.HKD","IE00BJJMRY28.SGD","LU0320765489.SGD","2NVD.UK","LU2168564495.EUR","LU1582986433.USD","LU1823568750.SGD","LU1989772923.USD","LU2404859667.USD","ESUM","LU0082616367.USD","IE000Q6AESB8.SGD","LU0823421416.USD","LU2168564149.EUR","LU2764263203.CNY","LU2360108059.USD","GAMR","LU0053666078.USD","LU0096362180.USD","IE00BDGV0183.EUR","LU2326559502.SGD","LU2054465674.USD","LU0109392836.USD","LU2065171402.SGD","CLSE","SG9999015358.SGD","IE00BSNM7G36.USD","ILDR","LU0069063385.USD","LU0345768740.USD","LU1221951046.USD","NVDA","IE00B3PB1722.GBP","BK4525","LU1992135472.HKD","LU2720916845.USD","LU0528227936.USD","LU0061474705.USD","IE000ITXATA3.USD","LU0203202063.USD","LU0348723411.USD","IE000SO60NU8.SGD","LU0211327993.USD","LU1989763005.USD","LU2237438978.USD","LU1066053197.SGD","LU2286300806.USD","LU0080751232.USD","LU1564329032.USD","IE00BJTD4V19.USD","LU1868836757.USD","LU1935043023.USD","LU2095319765.USD","LU0823421333.USD","LU2242649171.HKD","LU2357627491.SGD","LU1035775433.USD","LU2023250330.USD","LU2272731782.SGD","LU0942090050.USD","LU3102509885.SGD","LU0109391861.USD","LU0444971666.USD","SOXY","MSFO","LU0289739343.SGD","LU1153585028.USD","LU2491049909.HKD","LU2210149790.SGD","IE000MB6IJN5.SGD","BK4527","LU2244417387.USD","LU1974910355.USD","IE00B775SV38.USD","LU0898699433.AUD","LU2362540622.SGD","SGXZ23171101.USD","LU2077746001.SGD","THMR","LU0823417737.USD","BK4588","LU1301847155.USD","LU1003077747.HKD","LU2764263039.SGD","IE00BLSP4452.SGD","LU1066051225.USD","LU1582987324.SGD","MSFX","LU1935042991.SGD","JGRO","LU1121112475.USD","LU0265550946.USD","LU0347712357.USD","LU1244550577.SGD","LU0095938881.EUR","SG9999015945.SGD","LU1564329628.SGD","ESLG","LU1670710588.SGD","LU1280957306.USD","SG9999014880.SGD","BK4543","LU1069344957.HKD","BK4567","IE00BBT3K403.USD","LU2237443382.USD","METV","LU0234572021.USD","LU2063271972.USD","SGXZ51526630.SGD","LU0029864427.USD","IE0009356076.USD","LU2452424414.USD","SMH","LU0266013472.USD","IE00B1XK9C88.USD","LU0048584097.USD","HK0000914660.USD","LU0395794307.EUR","MSFC","TRFK","IE00B3M56506.USD","09388","LU2462591350.SGD","LU1951200564.SGD","LU0757359368.USD","LU2394011477.USD","IE000W1ABFV2.USD","LU2471134952.CNY","LU1059921491.USD","LU1670628061.USD","LU2168564065.EUR","IE00BKPKM429.USD","LU2249611893.SGD","LU2404859741.USD","LU1340139317.AUD","LU2275660780.HKD","IE0001KFT4U8.USD","LU1235295455.SGD","LU1778281490.HKD","LU1242518857.USD","LU0345769631.USD","LU1861127337.USD","IE00BKDWB100.SGD","IE000KEQY171.SGD","LU0345769128.USD","LU2125154778.USD","SG9999014559.SGD","LU2191332357.HKD","SNVDAmain","LU0823434583.USD","LU2047632596.USD","BK4503","LU2100268510.USD","LU2041044095.USD","LU1712237335.SGD","LU0081259029.USD","LU2430703095.HKD","LU0310800379.SGD","LU2133065610.SGD","IE00BDCRKT87.USD","LU2430703178.SGD","SG9999014542.SGD","DIPS","IE00BKVL7J92.USD","LFGY","LU1267930730.SGD","LU2491050154.USD","LU2111349929.HKD","LU0708994859.HKD","LU1935043452.HKD","LU2242650005.HKD","LU0215105999.USD","LU2168564222.USD","LU0094547139.USD","LU0690374615.EUR","SG9999001424.SGD","LU0672654240.SGD","LU2322448791.USD","SHOC","LU0225283273.USD","MSFT","LU2458330243.SGD","NVDD","LU1043141396.HKD","LU2065170008.USD","LU2102340556.USD","LU2089284900.SGD","LU0276348264.USD","LU0256863902.USD","NVDL","SG9999015341.SGD","IE0004445239.USD","BK4579","LU0314104364.USD","LU0784383803.USD","SG9999015978.USD","IE00B7KXQ091.USD","LU1585245621.USD","LU0210528500.USD","LU1435385759.SGD","LU0267386448.USD","LU0472753341.HKD","IE00BQXX3D17.EUR","LU1564329461.SGD","LU0786609619.USD","LU1923623000.USD","LU1064131342.USD","LU2458330169.SGD","LU0640476718.USD","IE0005OL40V9.USD","IE00B19Z8X17.USD","LU1366192091.USD","ANV","NVDU","LU2552382132.HKD","LU1732799900.SGD","LU2290526834.HKD","LU0965509101.SGD","LU0689472784.USD","LU1923622291.USD","LU0979878070.USD","IE00B42XCP33.USD","LU0302445910.USD","LU1721428933.USD","LU0072462426.USD","LU2125154935.USD","SG9999015986.USD","LU0661504455.SGD","LU1633808545.USD","LU2106854487.HKD","IE0009G5SDU7.USD","LU1228905540.USD","LU2089283258.USD","LU0353189680.USD","SGXZ44715902.SGD","IE0034235295.USD","LU0070217475.USD","BK4566","LU2491050071.SGD","LU1804176565.USD","LU0133085943.USD","LU2505996681.GBP","LU1934455194.USD","LU2473716301.USD","LU2552382215.SGD","IE00BFSS8Q28.SGD","SG9999014914.USD","LU0823414551.USD","LU0868494708.USD","LU0820561909.HKD","LU0985320562.USD","HK0000306685.HKD","LU0724617625.USD","LU0426417589.USD","LU0964807845.USD","LU1244550221.USD","LU2087621335.USD","NVDW","LU0210533765.USD","LU1868836914.USD","LU1035773651.USD","LU0792757196.USD","LU0345770993.USD","LU2602419157.SGD","SG9999018865.SGD","LU0912757837.SGD","LU2462591277.SGD","LU2092937148.SGD","WISE","IE00BK4W5M84.HKD","LU1815336760.USD","NVDS","LU2505996509.AUD","SPTE","LU0795875169.SGD","LU0965508806.USD","BK4614","LU0256863811.USD","LU0960925559.SGD","LU2125909759.SGD","LU0345774631.USD","SG9999001077.SGD","HK0000304797.USD","LU1119994496.HKD","SMSFTmain","LU1674673691.USD","LU0784385170.HKD","LU2361044865.SGD","IE00B3SWFQ91.USD","LU0868494617.USD","IE00BWXC8680.SGD","BK4535","LU0208291251.USD","NVD3.UK","LU0149725797.USD","IE00BJLML261.HKD","LU2461242641.AUD","LU2298321311.HKD","HK0000306701.USD","IE0034235303.USD","LU1582987597.SGD","LU0011850046.USD","IE00BFXG1179.USD","LU2362541273.HKD","IE00BMPRXQ63.HKD","FDTX","IE00BN29S564.USD","LU2360106780.USD","LU0642271901.SGD","IE00B19Z8W00.USD","SG9999002232.USD","SOXX","LU0320765059.SGD","SGXZ99366536.SGD","LU0345768153.USD","LU1564329115.USD","SG9999004303.SGD","LU1989764748.USD","IE00BJJMRX11.SGD","IE00BDRTCR15.USD","LU0823434740.USD","IE00B19Z9505.USD","AIFD","LU1670627923.USD","LU0174119429.USD","IE0034235188.USD","LU0203201768.USD","SGXZ31699556.SGD","HK0000320264.USD","IE00BHPRN162.USD","HK0000304805.HKD","IE00B5TLWC47.USD","LU2247934214.USD","LU1496350502.SGD","LU1032955483.USD","LU1196500208.SGD","BK4585","LU2065171311.SGD","LU0198837287.USD","LU2381873111.SGD","LU2125909593.SGD","BK4504","TTEQ","LU0690374961.EUR","LU2361045086.USD","LU1868837300.USD","IE000BZT7R73.USD","IE0004445015.USD","USXF","CNEQ","LU2764262908.HKD","BK4608","LU1670710661.SGD","LU2237443622.USD","LU0859254822.USD","LU1202635105.USD","LU0943347566.SGD","LU1429558221.USD","BK4587","LU0143551892.USD","SGXZ80539844.SGD","LU1691799644.USD","LU1188199696.SGD","LU2279689827.SGD","LU2746668974.SGD","EFIV","LU2506951875.HKD","LU1988902786.USD","IE0004086264.USD","LU0354030438.USD","LU2931357623.SGD","LU1069347547.HKD","LU2999663052.SGD","LU0323239441.USD","LU1400636657.SGD","LU1861215975.USD","NVDX","NVYY","LU2463028550.USD","LU0417517546.SGD","LU0128525929.USD","LU0265550359.USD","LU0210536198.USD","LU1236620750.USD","LU1316542783.SGD","LU1880398554.USD","FTEC","LU2637965513.SGD","IE00BVYPNV92.GBP","VGT","LU2089985449.USD","LU2456880835.USD","LU1861220033.SGD","LU0949170426.SGD","TEK","LU0957808578.USD","VT","IE00BMPRXR70.SGD","BK4612","LU1720051017.SGD","TYLG","LU0345770308.USD","LU2360032135.SGD","LU1334329650.SGD","LU2097344431.USD","LU2237957811.SGD","LU1046421795.USD","LU0158827948.USD","TTXU","07788","LU1732800096.USD","GB00BDT5M118.USD","SG9999015952.SGD","LU1674673428.USD","LU0162691827.USD","LU1571399168.USD","LU1718418525.SGD","LU2347655073.USD","LU2896262040.SGD","LU1935043536.SGD","LU2087625088.SGD","LU1145028129.USD","LU0545562505.USD","LU0310799852.SGD","LU1839511570.USD","LU0107464264.USD","LU1803068979.SGD","LU1127390331.HKD","NVDY","LU0353189763.USD","BK4533","LU2065169927.USD","LU0312595415.SGD","ABFL","LU2210150020.SGD","CHPX","BK4548","BK4598","LU0084288322.USD","NVDG","MSFW","LU0106261372.USD","LU0965509010.AUD","LU2543165471.USD","LU0949170772.SGD","LU0511384066.AUD","IE0003U64NQ7.SGD","LU0175139822.USD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677672449","title":"Jaguar says crofelemer shows benefit for IF in congenital enteropathy disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2677672449","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677672449?lang=en_us&edition=fundamental","pubTime":"2026-10-21 21:25","pubTimestamp":1792589146,"startTime":"0","endTime":"0","summary":"Jaguar Health (JAGX) announced that Jaguar family company Napo Pharmaceuticals has been continuing to provide the company’s novel crofelemer powder...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jaguar-says-crofelemer-shows-benefit-for-if-in-congenital-enteropathy-disorder-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jaguar-says-crofelemer-shows-benefit-for-if-in-congenital-enteropathy-disorder-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JAGX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677672361","title":"Lexaria Bioscience Reaches Full Enrollment in Oral Semaglutide Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2677672361","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677672361?lang=en_us&edition=fundamental","pubTime":"2026-10-21 21:25","pubTimestamp":1792589123,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Reaches Full Enrollment in Oral Semaglutide StudyLexaria Bioscience reported full enrollment in its GLP-1-H26-7 human pilot study on October 21, 2026, with dosing on schedule.The fi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL4DPPyy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LEXX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677672862","title":"Press Release: Decibel Comments on Tender Offer by Ewing Morris for up to 6.8% of Common Shares at $1.91 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2677672862","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677672862?lang=en_us&edition=fundamental","pubTime":"2026-10-21 21:24","pubTimestamp":1792589040,"startTime":"0","endTime":"0","summary":"to up to 2,617,801 Shares of the 38,469,551 Shares issued and. outstanding. If more Shares are deposited than Ewing Morris has offered. to purchase, Shares will be taken up on a pro rata basis. -- Cash price of $1.91 per Share. According to the Ewing Morris Release, the. Offer price represents a premium of approximately 16.4% to the. volume-weighted average price of the Shares on the TSX Venture Exchange. for the 20 trading days prior to the announcement of the Offer. The Offer. price also represents a premium of approximately 19.4% to the closing. price of $1.60 on October 16, 2026, the last trading day prior to the. -- No new Shares and no dilution. The Offer is for Shares already held by. shareholders. No securities are being issued by the Company and no. -- Minimum deposit and other conditions. The Offer is conditional on, among. other things, at least 1,745,200 Shares being validly deposited. The. Offer is also subject to a number of other conditions, many of which may. and after ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBCCF","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0115},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.029},{"period":"6month","weight":0.0855},{"period":"1year","weight":0.1456},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4007","nameEN":"BK4007"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmacy,BK4007,Pharmacy股票,Pharmacy股票老虎,Pharmacy股票老虎国际,Pharmacy行情,Pharmacy股票行情,Pharmacy股价,Pharmacy股市,Pharmacy股票价格,Pharmacy股票交易,Pharmacy股票购买,Pharmacy股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}